4.56
전일 마감가:
$4.57
열려 있는:
$4.52
하루 거래량:
386.88K
Relative Volume:
0.40
시가총액:
$147.23M
수익:
$160.43M
순이익/손실:
$-227.64M
주가수익비율:
-0.0663
EPS:
-68.77
순현금흐름:
$-170.79M
1주 성능:
-10.42%
1개월 성능:
+30.58%
6개월 성능:
+63.46%
1년 성능:
-73.16%
아제너스 Stock (AGEN) Company Profile
명칭
Agenus Inc
전화
781-674-4410
주소
3 FORBES ROAD, LEXINGTON, MA
AGEN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
AGEN
Agenus Inc
|
4.5408 | 147.23M | 160.43M | -227.64M | -170.79M | -68.77 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
454.68 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
543.45 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
319.93 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
558.74 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
243.00 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
아제너스 Stock (AGEN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2024-07-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2024-07-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-07-18 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2023-06-06 | 개시 | Robert W. Baird | Outperform |
2023-02-28 | 재개 | H.C. Wainwright | Buy |
2022-09-28 | 개시 | SMBC Nikko | Outperform |
2021-12-16 | 개시 | H.C. Wainwright | Buy |
2019-11-19 | 재개 | B. Riley FBR | Buy |
2019-04-22 | 개시 | B. Riley FBR | Buy |
2016-10-28 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2016-10-27 | 재확인 | Maxim Group | Buy |
2016-03-11 | 업그레이드 | Maxim Group | Hold → Buy |
2015-12-16 | 개시 | Jefferies | Buy |
2015-10-27 | 다운그레이드 | Maxim Group | Buy → Hold |
2015-07-27 | 재확인 | MLV & Co | Buy |
2015-06-11 | 개시 | Oppenheimer | Outperform |
2015-01-12 | 재확인 | Maxim Group | Buy |
2015-01-09 | 재확인 | MLV & Co | Buy |
2015-01-09 | 재확인 | Maxim Group | Buy |
2014-12-19 | 재확인 | Maxim Group | Buy |
2014-05-08 | 재확인 | Maxim Group | Buy |
2014-03-14 | 재확인 | MLV & Co | Buy |
2013-10-08 | 재확인 | Maxim Group | Buy |
2012-01-05 | 개시 | William Blair | Outperform |
2011-12-01 | 개시 | Global Hunter Securities | Buy |
모두보기
아제너스 주식(AGEN)의 최신 뉴스
# Agenus and Noetik partner to develop AI-powered cancer treatment biomarkers - Investing.com India
Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock - MSN
Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo - MarketScreener
Agenus (AGEN) and Noetik Collaborate to Enhance Cancer Treatment - GuruFocus
Agenus, Noetik Enter Research Collaboration - Nasdaq
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology | AGEN Stock News - GuruFocus
AI Breakthrough: Agenus and Noetik Join Forces to Revolutionize Cancer Patient Selection Using Virtual Cell Models - Stock Titan
10 Most Undervalued Stocks to Buy for Under $5 - Insider Monkey
Zydus Life To Buy Agenus' US Facilities For $75 Million For Entry In Biologics CDMO - MSN
Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire Inc.
Is Zydus’s Agenus Deal Opportunistic Or Strategic? - insights.citeline.com
Agenus Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire
H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN
Agenus Announces Virtual Annual Shareholders Meeting - New Castle News
How to Join Agenus 2025 Virtual Shareholders Meeting: Complete Registration Guide - Stock Titan
Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL - MSN
Agenus Inc. (NASDAQ:AGEN) Receives Consensus Rating of “Hold” from Analysts - Defense World
Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating - MSN
Research Analysts Issue Forecasts for Agenus FY2027 Earnings - Defense World
HC Wainwright Forecasts Agenus’ Q3 Earnings (NASDAQ:AGEN) - Defense World
Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million - Medical Dialogues
Zydus enters global biologics CDMO market with $75m facility acquisitions - BioProcess International
Agenus (NASDAQ:AGEN) Upgraded to “Buy” at HC Wainwright - Defense World
Agenus (NASDAQ:AGEN) Price Target Raised to $6.00 at Robert W. Baird - Defense World
Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL - Medical Dialogues
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - 뉴스와이어
Agenus Announces Strategic Collaboration with Zydus - TipRanks
Agenus IncSigns Partnership Agreements With Zydus Lifesciences - MarketScreener
Analyst Upgrades Agenus As Zydus Deal Alleviates Cash OverhangAgenus (NASDAQ:AGEN) - Benzinga
Agenus Shares Rise After Upgrade From HC Wainwright - marketscreener.com
H.C. Wainwright upgrades Agenus stock on strategic collaboration - Investing.com Australia
H.C. Wainwright upgrades Agenus stock on strategic collaboration By Investing.com - Investing.com South Africa
Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade - Yahoo Finance
Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Mai - GuruFocus
Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Maintained | AGEN Stock News - GuruFocus
Agenus (AGEN) Upgraded to 'Buy' by HC Wainwright & Co. | AGEN St - GuruFocus
HC Wainwright & Co. Upgrades Agenus (AGEN) - Nasdaq
Agenus (AGEN) Stock Price Target Increased by Baird | AGEN Stock News - GuruFocus
Agenus and Zydus sign agreements for botensilimab and balstilimab - Yahoo Finance
Zydus gets rights for next gen I-O platforms from Agenus - The Pharma Letter
HC Wainwright Upgrades Agenus to Buy From Neutral, $25 Price Target - marketscreener.com
Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | A - GuruFocus
Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | AGEN Stock News - GuruFocus
Zydus signs deal with Agenus for next-gen cancer immunotherapies - Healthcare Radius
Zydus to enter global biologics CDMO business to accelerate development of innovative therapies - Pharmabiz.com
Jane Street Group LLC Raises Stock Position in Agenus Inc. (NASDAQ:AGEN) - Defense World
Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilitiesto accelerate development of innovative therapies - APN News
Zydus to acquire Agenus’ US manufacturing facilities, forays into global biologics CDMO business - Indian Pharma Post
Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market - Express Pharma
Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - StreetInsider
Agenus inks $141M deal with Zydus for cancer drugs, facilities By Investing.com - Investing.com South Africa
아제너스 (AGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):